SILO PHARMA, INC. Weighted Average Basic Shares Outstanding, Pro Forma
SILO PHARMA, INC. (SILO) reported Weighted Average Basic Shares Outstanding, Pro Forma of 2.28 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-24.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageBasicSharesOutstandingProForma · last filed 2023-03-24
- SILO PHARMA, INC. weighted average basic shares outstanding, pro forma for fiscal 2022 was 2.28M shares, a 20.39% increase from fiscal 2021.
- SILO PHARMA, INC. weighted average basic shares outstanding, pro forma for fiscal 2021 was 1.90M shares.
| Period end | Weighted Average Basic Shares Outstanding, Pro Forma 12 month |
|---|---|
| 2022-12-31 | 2.28M shares 10-K · filed 2023-03-24 |
| 2021-12-31 | 1.90M shares 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |